Scottsdale, Az USA gettyWalgreens Boots Alliance WBA is in transformation. Just before announcing the year-end results in October, Tim Wentworth was appointed CEO of the company. Wentworth (64) comes from Cigna CI where he headed up Evernorth, the health services platform of that company.Prior to announcing Wentworth’s appointment there was an interim team headed by Ginger Graham (an independent Board member serving as CEO) and Manmohan Mahajan, who served as interim CFO CFO . It is likely that a more stabl ...

Blue-chip name Walgreens Boots Alliance Inc (NASDAQ:WBA) is gearing up for its fiscal first-quarter earnings report, which is due out before the open on Thursday, Jan. 4. Below, we will explore the equity's technical performance and previous post-earnings activity. On the charts, Walgreens Boots Alliance stock is still recovering from its late-November dip to record lows below the $20 area. The equity's 180-day moving average -- a long-term trendline of resistance -- is keeping a lid on any attempted gains ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that Chief Executive Officer, Tim Wentworth, and Interim Global Chief Financial Officer, Manmohan Mahajan, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, Jan. 8, at 8:15 a.m. PST. The appearance will be webcast live and can be accessed through the Walgreens Boots Alliance investor relations website. About Walgreens Boots Alliance Walgreens Boots Allianc ...

Dividend Kings sometimes become synonymous with being safe investments. And that's for good reason as they have stellar track records of increasing their dividend payments for at least 50 consecutive years. It's an impressive achievement, which the vast majority of dividend stocks are nowhere near.One stock that is close to achieving that status is Walgreens Boots Alliance (WBA 1.71%). If its dividend increases over the next couple of years, the pharmacy retail giant could join the exclusive club of Dividen ...

公司表现 - 沃尔格林联盟（Walgreens Boots Alliance）股票今年迄今已经下跌了32%，创下自2009年以来的新低[1] - 公司近年来一直在朝着增长目标转变，包括在其门店开设初级诊所，但在这一过程中一直难以摆脱亏损[2] - 新任CEO Tim Wentworth面临着艰巨的挑战，公司股票表现糟糕，门店不再因COVID-19疫苗接种而吸引顾客，过去四个季度中有三个季度出现营运亏损[5]

Fourth Quarter and Fiscal 2023 Results October 12, 2023 ...

销售情况 - 公司在财政2023年度的销售中，药房销售占74%，零售销售占26%[33] - 公司在财政2023年度的药房销售中，约97%的销售来自于从托管保健组织、政府机构、处方药计划管理机构和私人保险处获得的报销[34] - 公司在财政2023年度的销售中，约23%来自于为联邦医疗保险处方药计划和约6%来自于医疗补助计划的处方药销售[35] - 公司的国际业务中，药房销售占17%，零售销售占33%，批发销售占51%[53] 药房业务挑战 - 公司的药房业务受到持续的处方报销压力、处方每30天向90天的转变、增加的联邦医疗保险处方数量以及消费者使用处方折扣卡的增加影响[40] - 公司不断面临来自处方药管理机构、政府、健康维护组织、托管保健组织和其他商业第三方支付者的报销压力[41] - 公司已努力发展和扩大与商业第三方支付者的关系，以通过参与他们提供的药房提供者网络获得新的和/或改进的市场准入[42] - 公司的90天零售处方药提供的利润率通常低于相应的30天处方，但为公司提供了与患有慢性处方需求的患者增加业务的机会，同时提供了更多便利，有助于促进处方依从性并降低填充90天处方的成本[43] 国际业务 - 公司的国际业务包括在美国以外的药房为主导的健康和美容零售业务以及在德国的制药批发和分销业务[44] 员工关怀 - 公司的薪酬和福利旨在关心员工的整体健康，提供全面的福利，包括医疗保险、保险福利、数字健康计划等[80] - 公司认为员工的参与直接转化为业务成功，进行全球员工参与调查以帮助公司衡量和提高员工参与度[82] - 公司致力于为员工、客户、承包商和患者创造和维护安全环境，设有健康、安全和环境委员会不断改进健康和安全管理[89] 财务表现 - 2023财年销售额为222亿美元，同比增长1.7%[349] - 2023财年毛利润为47.04亿美元，同比增长1.9%[349] - 2023财年营业利润为3.79亿美元，较去年同期增长[349] - 2023财年调整后营业利润为9.35亿美元，较去年同期增长[349] - 2023财年零售销售同比增长5.8%[357] - 2023财年药店销售同比下降1.7%[356] - 2023财年销售中英国Boots业务增长9.0%[355] - 2023财年销售中德国批发业务增长4.7%[355] - 2023财年销售中美国零售业务增长12.1%[357] - 2023财年运营利润主要受英国Boots业务增长和德国业务执行影响[361] 财务报表 - 公司在2023财年录得了来自其他收入的1090万美元的税前收益，主要是由于将之前持有的Option Care Health的股权投资分类为公平价值持有的股权投资，并随后相关的公允价值调整[395] - 公司在2022财年录得了22亿美元和4.02亿美元的税前收益，分别与VillageMD和Shields的股权投资分类变更相关，这些收益记录在其他收入中[395] - 公司在2023和2022财年录得了来自其他收入的收益，主要是由于部分出售其在Cencora的投资和完全出售其在Option Care Health的股权法投资[396] - 公司在2022财年因与Shields整合相关的债务提前清偿而录得了400万美元的损失，2021财年因现金收购部分债务而录得了4.19亿美元的损失[397] - 公司对所得税（利益）准备金进行调整，包括与非GAAP调整和某些离散税务项目相关的调整，这些费用记录在所得税（利益）准备金中[398]

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q4 2023 Earnings Conference Call October 12, 2023 8:30 AM ET Company Participants Tiffany Kanaga - Vice President, Global Investor Relations Tim Wentworth - Chief Executive Officer Ginger L. Graham - Interim Chief Executive Officer Manmohan Mahajan - Interim Global Chief Financial Officer John Driscoll - President of U.S. Healthcare Rick Gates - Senior Vice President and Chief Pharmacy Officer Conference Call Participants Lisa Gill - JP Morgan Charles Rhyee - TD C ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q3 2023 Earnings Conference Call June 27, 2023 8:30 AM ET Company Participants Tiffany Kanaga - Vice President, Global Investor Relations Roz Brewer - Chief Executive Officer James Kehoe - Chief Financial Officer John Driscoll - President of U.S. Healthcare Rick Gates - Senior Vice President and Chief Pharmacy Officer Conference Call Participants Lisa Gill - JP Morgan George Hill - Deutsche Bank Ann Hynes - Mizuho Securities Michael Cherny - Bank of America Merril ...

Reimagining Local Healthcare and Wellbeing for All Third Quarter Fiscal 2023 Results June 27, 2023 ...